The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468.
Taiwan Semiconductor Manufacturing TSM
Titan Ethical
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East,…
read at $415.17
Taiwan Semiconductor Manufacturing holds its Accumulation at $415.17.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · insiders bought, latest filing 2026-06-29
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 282 days |
| Price | $415.17 |
| Valuation | 35.13 trailing · 21.22 forward price to earnings |
| Values screen | PASS · score 50.0 |
| Beta | 1.26 |
The values screen, explained · five checks, plain English
Full pass across all five screens. This security clears the Titan Ethical Standard — its business and its balance sheet both stay inside the lines.
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Five checks adapted from AAOIFI screening standards — business activity plus four balance-sheet ratios. All five must pass for ethical clearance.
The opportunity · what the numbers say it is worth
Our framework reads FAIR VALUE — it trades above our $313.24 fair value estimate, strong competitive moat, 35.10% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 35.10% |
| Profit margin | 46.50% |
| Debt to equity | 0.17 |
| Analyst consensus | None · 18 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The business, in plain words · what the numbers mean
Why it is worth knowing
A quality business — a strong moat and 47% profit margins. At today's price it sits 25% above our $313.24 fair value — priced for the quality, not a bargain.
| Forward P/E | 21.2x cheap for a company growing this fast |
| Trailing P/E | 35.1x expensive — the price assumes strong growth ahead |
| Revenue growth | 35.1% strong top-line growth |
| Profit margin | 46.5% highly profitable on every dollar of sales |
| Return on equity | 36.2% an exceptional return on shareholder capital |
| Debt to equity | 0.17 minimal debt — a conservative balance sheet |
| Current ratio | 2.49 comfortably covers its short-term bills |
| Beta | 1.26 moves a little more than the market |
| Market cap | $2.32T |
| Employees | 76,907 |
The risks · The things to watch: its business and earnings are exposed to Taiwan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & how to trade · wherever in the world you are
TSM trades on NYSE (ADR) (the company is based in Taiwan). As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468. It reported earnings in this window, a natural checkpoint for the thesis.
5 July 2026 — $415.17 — ACCUMULATION (state model: sideways, 282 days). Journal opened. The quiet season on the irreplaceable company: quality 92, forward 21 times, discount geopolitical not financial. Tensions on file: values pass with zero headroom at 50; insider VP raised stake 18% late June. Watch: the nine-month range edges, the screen line, fab geography.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-29 | Tien Bor-Zen | VP | Purchase | 2,000 | $18 |
| 2026-04-28 | TIEN BOR-ZEN | Officer | 20 | $7,760 | |
| 2026-03-31 | BURNS URSULA M | Director | 1,000 | $322,050 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 8 May2026 | Rick Allen | Republican | buy | 1K–15K |
| 8 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $404.54 | +1.1% | · | $1,011 | +1.1% |
| 2 months | $370.60 | +10.3% | · | $1,103 | +10.3% |
| 3 months | $335.76 | +21.8% | $0.96 | $1,221 | +22.1% |
| 6 months | $303.99 | +34.5% | $0.96 | $1,348 | +34.8% |
| 1 year | $209.86 | +94.9% | $3.39 | $1,965 | +96.5% |
| 2 years | $163.81 | +149.6% | $5.86 | $2,532 | +153.2% |
| 3 years | $98.34 | +315.8% | $7.82 | $4,237 | +323.7% |
| 5 years | $108.84 | +275.7% | $11.56 | $3,863 | +286.3% |
Historical returns from market close data. Past performance does not guarantee future results.